Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.
Business Model:
Revenue: $3.8M
Employees: 51-200
Address:
City: Boulder
State: Colorado
Zip:
Country: United States
Signum Biosciences is a private biotechnology company dedicated to developing small-molecule therapeutics derived from its Signal Transduction Modulation (STM) platform to modulate signal transduction imbalances. Through research on protein networks that control biological systems, Signum is developing therapeutic agents for several skin conditions, Alzheimer&s;s, Parkinson&s;s, asthma and COPD. Signum&s;s STM technology provides many opportunities for the development of novel consumer products and pharmaceutical candidates.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2013 | Grant | $1.6M | 4/2007 | Venture Round | 1 | - |
New Jersey Economic Development Authority New Jersey Economic Development Authority |
7/2011 | Venture Round | $4M | 4/2007 | Venture Round | 1 | - |
New Jersey Economic Development Authority New Jersey Economic Development Authority |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|